AI assistant
Solana Co — Director's Dealing 2018
May 17, 2018
32724_dirs_2018-05-17_3626247f-1227-4551-8d89-076749064f36.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HELIUS MEDICAL TECHNOLOGIES, INC (HSDT)
CIK: 0001610853
Period of Report: 2018-03-15
Reporting Person: Sackier Jonathan (Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-03-15 | Class A Common Stock | J | 62002 | $0.00 | Acquired | 703403 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-05-15 | Employee Stock Option (Right to Buy) | $10.99 | A | 80000 | Acquired | 2028-05-15 | Class A Common Stock (80000) | Direct |
Footnotes
F1: Pro rata distribution from Clinvue LLC, of which the Reporting Person was a member.
F2: The amount reported reflects a pro rata distribution to members of MPJ Healthcare. In prior reports, the Reporting Person reported beneficial ownership of 641,401 shares, on a post-split basis.
F3: Translated into US dollars from Canadian dollars based on buying rate from Bank of Canada. USD $1.0000 = CAD $1.2876 on May 15, 2018; based on exercise price of CAD $14.15.
F4: Grant to the Reporting Person of a stock option under the Issuer's 2016 Omnibus Incentive Plan (the "2016 Plan"). The shares vest in a series of forty-eight (48) successive equal monthly installments measured from May 15, 2018, subject to the Reporting Person's continued service through each applicable vesting date.